Answers are grounded in this paper and cite their sources.
Neurosyphilis covers a broad spectrum of neurological syndromes arising after central nervous system (CNS) infection with Treponema pallidum . The disorder was once framed as parenchymal degeneration or single-direction vascular injury, which is proposed primarily for meningovascular and border- compartment neurosyphilis, it is now seen as a multifactorial illness rooted in the meningeal-vascular-CSF interface. Work on the immune functions of the brain’s border tissues—the dura and arachnoid, together with the pial perivascular (glymphatic) spaces, has drawn meningeal macrophages, dural immune reservoirs, perivascular glymphatic exchange, meningeal lymphatics, and skull-meninges channels together into a single neuroimmune system that links pathogen surveillance, waste removal, and immune memory. We combine clinical, immunological, and radiological data to view neurosyphilis through this lens. Sparse surface antigens and antigenic variation permit Treponema pallidum to remain intrathecally, keeping TLR signaling and endothelial activation ongoing and maintaining steep gradients of intrathecal CXCL13 that draw B cells in and fuel lymphoplasmacytic expansion. Meningovascular-type proliferative endarteritis together with astrocytic reactivity harms blood-CSF barrier integrity, arterial-wall pulsatility, and AQP4 polarization, potentially leading to glymphatic stasis and reduced dural lymphatic drainage. Antigens, cytokines, and metabolic waste that cannot be cleared sustain a self-reinforcing immunopathological loop at the CNS borders. We propose that impaired meningeal fluid clearance, driven by chronic meningovascular inflammation, acts as a self-reinforcing component of neurosyphilis pathogenesis. The framework integrates clinical, immunological, and radiological evidence and generates testable predictions that can be directly examined in future studies. The framework is proposed primarily for meningovascular and border-compartment neurosyphilis. We close by outlining a translational agenda centered on combined clearance imaging, with standardized temporal sampling, fluid-tissue single-cell multi-omics, and methods including DTI-ALPS and vessel-wall MRI, to move care from descriptive laboratory results toward mechanism-based endotyping and precision treatment.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: